Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report elaborates on the current development of the Imatinib Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sanofi SA
Apotex Inc
Actavis Generics
Sun Pharmaceuticals
Cipla Inc
Glenmark Pharmaceuticals Ltd
Dr Reddy's Laboratories
Teva Pharmaceutical Industries Ltd
Novartis
By Type:
Capsules
Tablets
By Application:
Others
Gastrointestinal Stromal Tumors
Chronic Myelogenous Leukemia
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Imatinib Drug Market Overview 2018-2029
-
1.1 China Imatinib Drug Industry Development Overview
-
1.2 China Imatinib Drug Industry Development History
-
1.3 China Imatinib Drug Industry Market Size (2018-2029)
-
1.4 China Imatinib Drug Market Analysis by Type from Production Side
-
1.4.1 China Imatinib Drug Production Volume, Production Value and Growth Rate of Capsules (2018-2029)
-
1.4.2 China Imatinib Drug Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
1.5 China Imatinib Drug Market Analysis by Application from Consumption End
-
1.5.1 China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal Stromal Tumors (2018-2029)
-
1.5.3 China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Chronic Myelogenous Leukemia (2018-2029)
-
1.6 China Imatinib Drug Market Analysis by Region
-
1.6.1 North China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Imatinib Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Imatinib Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Imatinib Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Imatinib Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Imatinib Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Imatinib Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Imatinib Drug Industry Development
Chapter 3 Imatinib DrugIndustry Chain Analysis
-
3.1 Imatinib Drug Industry Chain
-
3.2 Imatinib Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Imatinib Drug Market
-
3.3 Imatinib Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Imatinib Drug Market
Chapter 4 China Imatinib Drug Market, by Type
-
4.1 China Imatinib Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Imatinib Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Imatinib Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Imatinib Drug Production Volume and Growth Rate of Capsules
-
4.5.2 China Imatinib Drug Production Volume and Growth Rate of Tablets
Chapter 5 China Imatinib Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Imatinib Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Imatinib Drug Market Size and Growth Rate, by Application
-
5.5.1 China Imatinib Drug Market Size and Growth Rate of Others
-
5.5.2 China Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors
-
5.5.3 China Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia
Chapter 6 China Imatinib Drug Market, by Region
-
6.1 China Imatinib Drug Production Volume and Production Value, by Region
-
6.2 China Imatinib Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Imatinib Drug Market Analysis
-
7.1 North China Imatinib Drug Market, by Type
-
7.2 North China Imatinib Drug Market, by Application
Chapter 8 Central China Imatinib Drug Market Analysis
-
8.1 Central China Imatinib Drug Market, by Type
-
8.2 Central China Imatinib Drug Market, by Application
Chapter 9 South China Imatinib Drug Market Analysis
-
9.1 South China Imatinib Drug Market, by Type
-
9.2 South China Imatinib Drug Market, by Application
Chapter 10 East China Imatinib Drug Market Analysis
-
10.1 East China Imatinib Drug Market, by Type
-
10.2 East China Imatinib Drug Market, by Application
Chapter 11 Northeast China Imatinib Drug Market Analysis
-
11.1 Northeast China Imatinib Drug Market, by Type
-
11.2 Northeast China Imatinib Drug Market, by Application
Chapter 12 Southwest China Imatinib Drug Market Analysis
-
12.1 Southwest China Imatinib Drug Market, by Type
-
12.2 Southwest China Imatinib Drug Market, by Application
Chapter 13 Northwest China Imatinib Drug Market Analysis
-
13.1 Northwest China Imatinib Drug Market, by Type
-
13.2 Northwest China Imatinib Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Sanofi SA
-
14.1.1 Sanofi SA Company Profile
-
14.1.2 Sanofi SA Imatinib Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Apotex Inc
-
14.2.1 Apotex Inc Company Profile
-
14.2.2 Apotex Inc Imatinib Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Actavis Generics
-
14.3.1 Actavis Generics Company Profile
-
14.3.2 Actavis Generics Imatinib Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Sun Pharmaceuticals
-
14.4.1 Sun Pharmaceuticals Company Profile
-
14.4.2 Sun Pharmaceuticals Imatinib Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Cipla Inc
-
14.5.1 Cipla Inc Company Profile
-
14.5.2 Cipla Inc Imatinib Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Glenmark Pharmaceuticals Ltd
-
14.6.1 Glenmark Pharmaceuticals Ltd Company Profile
-
14.6.2 Glenmark Pharmaceuticals Ltd Imatinib Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Dr Reddy's Laboratories
-
14.7.1 Dr Reddy's Laboratories Company Profile
-
14.7.2 Dr Reddy's Laboratories Imatinib Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Teva Pharmaceutical Industries Ltd
-
14.8.1 Teva Pharmaceutical Industries Ltd Company Profile
-
14.8.2 Teva Pharmaceutical Industries Ltd Imatinib Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Imatinib Drug Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Imatinib Drug Industry Research Conclusions
-
15.2 Imatinib Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Imatinib Drug Industry Market Size (2018-2029)
-
Figure China Imatinib Drug Production Volume, Production Value and Growth Rate of Capsules (2018-2029)
-
Figure China Imatinib Drug Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
Figure China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Gastrointestinal Stromal Tumors (2018-2029)
-
Figure China Imatinib Drug Sales Volume, Sales Value and Growth Rate of Chronic Myelogenous Leukemia (2018-2029)
-
Figure North China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Imatinib Drug Market Size and Growth Rate from 2018-2029
-
Figure Imatinib Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Imatinib Drug Market Share by Type in 2018
-
Figure China Imatinib Drug Market Share by Type in 2023
-
Figure China Imatinib Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Imatinib Drug Production Volume and Growth Rate of Capsules (2018-2023)
-
Figure China Imatinib Drug Production Volume and Growth Rate of Tablets (2018-2023)
-
Figure China Imatinib Drug Market Share by Application in 2018
-
Figure China Imatinib Drug Market Share by Application in 2023
-
Figure China Imatinib Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Imatinib Drug Market Size and Growth Rate of Others (2018-2023)
-
Figure China Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors (2018-2023)
-
Figure China Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia (2018-2023)
-
Table China Imatinib Drug Production Volume by Region (2018-2023)
-
Table China Imatinib Drug Production Volume Share by Region (2018-2023)
-
Figure China Imatinib Drug Production Volume Share by Region (2018-2023)
-
Table China Imatinib Drug Production Value by Region (2018-2023)
-
Table China Imatinib Drug Production Value Share by Region (2018-2023)
-
Figure China Imatinib Drug Production Value Share by Region (2018-2023)
-
Table China Imatinib Drug Sales Volume by Region (2018-2023)
-
Table China Imatinib Drug Sales Volume Share by Region (2018-2023)
-
Figure China Imatinib Drug Sales Volume Share by Region (2018-2023)
-
Table China Imatinib Drug Sales Value by Region (2018-2023)
-
Table China Imatinib Drug Sales Value Share by Region (2018-2023)
-
Figure China Imatinib Drug Sales Value Share by Region (2018-2023)
-
Table North China Imatinib Drug Production Volume by Type (2018-2023)
-
Table North China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure North China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table North China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table North China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Imatinib Drug Production Volume by Type (2018-2023)
-
Table Central China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table Central China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table Central China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table South China Imatinib Drug Production Volume by Type (2018-2023)
-
Table South China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure South China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table South China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table South China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table East China Imatinib Drug Production Volume by Type (2018-2023)
-
Table East China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure East China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table East China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table East China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Imatinib Drug Production Volume by Type (2018-2023)
-
Table Northeast China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Imatinib Drug Production Volume by Type (2018-2023)
-
Table Southwest China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Imatinib Drug Production Volume by Type (2018-2023)
-
Table Northwest China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Imatinib Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Imatinib Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Imatinib Drug Sales Volume Share by Application (2018-2023)
-
Table Sanofi SA Company Profile
-
Table Sanofi SA Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Apotex Inc Company Profile
-
Table Apotex Inc Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Actavis Generics Company Profile
-
Table Actavis Generics Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Sun Pharmaceuticals Company Profile
-
Table Sun Pharmaceuticals Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Cipla Inc Company Profile
-
Table Cipla Inc Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Glenmark Pharmaceuticals Ltd Company Profile
-
Table Glenmark Pharmaceuticals Ltd Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Dr Reddy's Laboratories Company Profile
-
Table Dr Reddy's Laboratories Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Ltd Company Profile
-
Table Teva Pharmaceutical Industries Ltd Imatinib Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Imatinib Drug Revenue, Price and Gross (2018-2023)
-
